-+ 0.00%
-+ 0.00%
-+ 0.00%

Incannex to Launch DReAMzz Phase 2 Crossover Dose-Optimization Study for IHL-42X and Advance a Streamlined Phase 3 Program Toward Potential Registration in Obstructive Sleep Apnea

Reuters·03/12/2026 12:08:47

Please log in to view news